Table 2.
Group: Vaccine treatment | Day | Back-trans-formed LSM | Back-transformed SE | Range | Back-transformed 95% CI |
---|---|---|---|---|---|
Subunit-AC | 0 | 33 | 8 | 13–200 | 21–52 |
21 | 493 | 111 | 100–1600 | 314–772 | |
35 | 36,205 | 8189 | 12,800–102,400 | 23,102–56,735 | |
Bacterin-1 | 0 | 54 | 12 | 25–200 | 34–84 |
21 | 348 | 79 | 200–800 | 222–546 | |
35 | 2599 | 588 | 400–6400 | 1659–4073 | |
Subunit-A | 0 | 38 | 9 | 13–200 | 24–59 |
21 | 57 | 13 | 25–200 | 37–90 | |
35 | 71 | 16 | 25–200 | 45–111 | |
Bacterin-2 | 0 | 33 | 8 | 13–100 | 21–52 |
21 | 66 | 15 | 50–200 | 42–103 | |
35 | 246 | 56 | 50–800 | 157–386 |
Osp, outer surface protein; LSM, least squares mean; SE, standard error; 95% CI, 95% confidence intervals.